OKYO Pharma Statistics
Share Statistics
OKYO Pharma has 33.89M
shares outstanding. The number of shares has increased by 1.96%
in one year.
| Shares Outstanding | 33.89M |
| Shares Change (YoY) | 1.96% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 0.13% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 1,196 |
| FTD / Avg. Volume | 1.16% |
Short Selling Information
The latest short interest is 153.67K, so 0.45% of the outstanding
shares have been sold short.
| Short Interest | 153.67K |
| Short % of Shares Out | 0.45% |
| Short % of Float | 0.63% |
| Short Ratio (days to cover) | 3.56 |
Valuation Ratios
The PE ratio is -2563.69 and the forward
PE ratio is -12.31.
OKYO Pharma's PEG ratio is
25.66.
| PE Ratio | -2563.69 |
| Forward PE | -12.31 |
| PS Ratio | 0 |
| Forward PS | n/a |
| PB Ratio | -7.34 |
| P/FCF Ratio | -4.55 |
| PEG Ratio | 25.66 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for OKYO Pharma.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.21,
with a Debt / Equity ratio of 0.
| Current Ratio | 0.21 |
| Quick Ratio | 0.21 |
| Debt / Equity | 0 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -0.01 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-5,608.49 |
| Employee Count | 3 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 22.42 |
| Effective Tax Rate | -0.13% |
Stock Price Statistics
The stock price has increased by 0.65% in the
last 52 weeks. The beta is -4.15, so OKYO Pharma's
price volatility has been lower than the market average.
| Beta | -4.15 |
| 52-Week Price Change | 0.65% |
| 50-Day Moving Average | 1.3 |
| 200-Day Moving Average | 1.15 |
| Relative Strength Index (RSI) | 67.67 |
| Average Volume (20 Days) | 103,073 |
Income Statement
| Revenue | n/a |
| Gross Profit | -7.51K |
| Operating Income | -15.75K |
| Net Income | -16.83K |
| EBITDA | -15.75K |
| EBIT | -15.75K |
| Earnings Per Share (EPS) | 0 |
Full Income StatementBalance Sheet
The company has 826.85K in cash and 0 in
debt, giving a net cash position of 826.85K.
| Cash & Cash Equivalents | 826.85K |
| Total Debt | n/a |
| Net Cash | n/a |
| Retained Earnings | -142.52M |
| Total Assets | 2.83M |
| Working Capital | -7.23M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -9.49M
and capital expenditures -3, giving a free cash flow of -9.49M.
| Operating Cash Flow | -9.49M |
| Capital Expenditures | -3 |
| Free Cash Flow | -9.49M |
| FCF Per Share | -0.32 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
